Risk of stroke associated with nonsteroidal anti-inflammatory drugs

Research output: Contribution to journalReview articlepeer-review

31 Scopus citations

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs), both cyclooxygenase (COX)-2-selective and nonselective agents, have been associated with the increased risk of adverse cardiovascular events. The majority of studies have focused on myocardial infarction as the primary cardiovascular outcome. However, the association between NSAIDs and the risk of stroke events is not as clear, although an understanding of this association is important since stroke continues to be a significant cause of morbidity and mortality. Various factors may contribute to an association between NSAIDs and stroke, including hypertension and thrombosis. Additionally, the risk may vary with different NSAID types. In this review, we discuss the relevant literature assessing the possible association between NSAID use and stroke events, along with the potential mechanisms and the possible directions for future study.

Original languageEnglish (US)
Pages (from-to)25-32
Number of pages8
JournalVascular health and risk management
Volume10
DOIs
StatePublished - 2014
Externally publishedYes

Keywords

  • Adverse events
  • Cardiovascular
  • Cyclooxygenase
  • Nonsteroidal anti-inflammatory drugs
  • Stroke

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Hematology
  • Public Health, Environmental and Occupational Health
  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Risk of stroke associated with nonsteroidal anti-inflammatory drugs'. Together they form a unique fingerprint.

Cite this